Journal of the Formosan Medical Association
Volume 105, Issue 11 , Pages 946-949, 2006

Coexistence of Pernicious Anemia and Myasthenia Gravis—A Rare Combination of Autoimmune Diseases in Taiwan

  • Kuo-Hsuan Chang

      Affiliations

    • Section of Neuromuscular Diseases, Department of Neurology, Chang Gung Memorial Hospital and University College of Medicine, Taipei, Taiwan
    • Department of Internal Medicine, Nan Men General Hospital, Hsinchu, Taiwan
    • ,
  • Rong-Kuo Lyu

      Affiliations

    • Section of Neuromuscular Diseases, Department of Neurology, Chang Gung Memorial Hospital and University College of Medicine, Taipei, Taiwan
    • ,
  • Long-Sun Ro

      Affiliations

    • Section of Neuromuscular Diseases, Department of Neurology, Chang Gung Memorial Hospital and University College of Medicine, Taipei, Taiwan
    • ,
  • Yih-Ru Wu

      Affiliations

    • Section of Neuromuscular Diseases, Department of Neurology, Chang Gung Memorial Hospital and University College of Medicine, Taipei, Taiwan
    • ,
  • Chiung-Mei Chen

      Affiliations

    • Section of Neuromuscular Diseases, Department of Neurology, Chang Gung Memorial Hospital and University College of Medicine, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Chiung-Mei Chen, Section of Neuromuscular Diseases, Department of Neurology, Chang Gung Memorial Hospital and University College of Medicine, 199 Tung Hwa North Road, Taipei 105, Taiwan

Received 17 August 2005; received in revised form 27 September 2005; accepted 6 December 2005.

Article Outline

About 5-10% of patients with myasthenia gravis concomitantly have other autoimmune diseases. However, the coexistence of myasthenia gravis and pernicious anemia is rare. Here, we report a 73-year-old Taiwanese woman who developed myasthenia gravis 5 months after the onset of pernicious anemia. Her myasthenic and pernicious anemia symptoms markedly improved after pyridostigmine, prednisolone and hydroxo-cobalamine treatment. It is important to recognize concurrence of myasthenia gravis and pernicious anemia in the same patient because the therapeutic results for both diseases are rewarding.

Key Words:  myasthenia gravis , pernicious anemia

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Richman DP , Agius MA . Acquired myasthenia gravis. Immunopathology . Neurol Clin . 1994;12:273–284
  2. Howard FM , Silverstein MN , Mulder DW . The coexistence of myasthenia gravis and pernicious anemia . Am J Med Sci. . 1965;250:518–526
  3. Krol TC . Myasthenia gravis, pernicious anemia, and Hashimoto's thyroiditis . Arch Neurol. . 1979;36:594–595
  4. Zittoun J , Tulliez M , Estournet B , et al.   Humoral and cellular immunity to intrinsic factor in myasthenia gravis . Scand J Haematol . 1979;23:442–448
  5. Samloff IM , Kleinman MS , Turner MD , et al.   Blocking and binding antibodies to intrinsic factor and parietal call antibody in pernicious anemia . Gastroenterology . 1968;55:575–583
  6. Davidson S . Clinical picture of pernicious anaemia prior to introduction of liver therapy in 1926 and in Edinburgh subsequent to 1944 . Br Med J . 1957;32:241–243
  7. Ehrenfeld EN , De Vries A . Bone marrow findings in a case of pernicious anemia, complicated by acute infection . Acta Haematol . 1950;4:86–91
  8. Scalabrino G . Cobalamin in subacute combined degeneration and beyond: traditional interpretations and novel theories . Exp Neurol. . 2005;192:463–479
  9. Richman DP , Patrick J , Arnason BG . Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes . N Engl J Med. . 1976;294:694–698
  10. Handa SI , Schofield KP , Sivakumaran M , et al.   Pure red cell aplasia associated with malignant thymoma, myasthe-nia gravis, polyclonal large granular lymphocytosis and clonal thymic T cell expansion . J Clin Pathol . 1994;47:676–679
  11. Simpson JA . Myasthenia gravis: a new hypothesis . Scot Med J . 1960;5:419–439
  12. Beekman R , Kuks JB , Oosterhuis HJ . Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients . J Neurol. . 1997;244:112–118
  13. Downes JM , Greenwood BM , Wray SH . Auto-immune aspects of myasthenia gravis . Q J Med. . 1966;35:85–105
  14. Kanazawa H , Eguchi K , Mine M , et al.   Serum from patients with autoimmune diseases induces in vitro production of disease-associated antibodies by peripheral blood mononuclear cells from normal subjects . J Clin Endocrinol Metab . 1986;63:683–688
  15. De Block CE , De Leeuw IH , Van Gaal LF . High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry . J Clin Endocrinol Metab . 1999;84:4062–4067
  16. Mantegazza R , Beghi E , Pareyson D , et al.   A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy . J Neurol. . 1990;237:339–344
  17. Tuncer EN , Ratip S , Ince-Gunal D , et al.   Myasthenia gravis with thymoma and autoimmune haemolytic anaemia. A case report . Neurol Sci. . 2003;24:34–36
  18. Alarc'on-Segovia  , Galbraith RF , Maldonado JE , et al.   Systemic lupus erythematosus following thymectomy for myasthe-nia gravis. Report of two cases . Lancet . 1963;186:662–665

PII: S0929-6646(09)60181-9

doi:10.1016/S0929-6646(09)60181-9

Journal of the Formosan Medical Association
Volume 105, Issue 11 , Pages 946-949, 2006

Article Tools